Sevoflurane inhibits equine myeloperoxidase release and activity in vitro

Authors

  • Grégory Minguet,

    1. Department of Anaesthesia and Intensive Care Medicine, CHU de Liège, Domaine Universitaire du Sart-Tilman, Liège, Belgium
    Search for more papers by this author
  • Geoffroy de la Rebière,

    1. Department of Clinical Sciences, Large Animal Surgery, Faculty of Veterinary Medicine, University of Liège, Domaine Universitaire du Sart-Tilman, Liège, Belgium
    Search for more papers by this author
  • Thierry Franck,

    1. Department of Clinical Sciences, Large Animal Surgery, Faculty of Veterinary Medicine, University of Liège, Domaine Universitaire du Sart-Tilman, Liège, Belgium
    Search for more papers by this author
  • Jean Joris,

    1. Department of Anaesthesia and Intensive Care Medicine, CHU de Liège, Domaine Universitaire du Sart-Tilman, Liège, Belgium
    Search for more papers by this author
  • Didier Serteyn,

    1. Department of Clinical Sciences, Large Animal Surgery, Faculty of Veterinary Medicine, University of Liège, Domaine Universitaire du Sart-Tilman, Liège, Belgium
    Search for more papers by this author
  • Charlotte Sandersen

    1. Department of Clinical Sciences, Large Animal Surgery, Faculty of Veterinary Medicine, University of Liège, Domaine Universitaire du Sart-Tilman, Liège, Belgium
    Search for more papers by this author

Grégory Minguet, Department of Anaesthesia and Intensive Care Medicine, CHU de Liège, B35 Domaine Universitaire du Sart Tilman, B-4000 Liège 1, Belgium. E-mail: gminguet@chu.ulg.ac.be

Abstract

Objective  To investigate the effects of the volatile anaesthetic sevoflurane on the release of total and active myeloperoxidase (MPO) by non-stimulated and stimulated polymorphonuclear neutrophils (PMNs) in whole blood from healthy horses.

Study design  In vitro experimental study.

Animals  Adult healthy horses.

Methods  Samples of whole venous blood were collected and incubated in air or in air plus 2.3% or 4.6% sevoflurane for 1 hour. PMNs were stimulated with N-formyl-methionyl-leucyl-phenylalanine (fMLP), with a combination of cytochalasin B (CB) and fMLP or with phorbol myristate acetate (PMA). Total and active MPO contents released by PMNs in blood were measured by enzyme-linked immunosorbent assay (ELISA) and specific immunological extraction followed by enzymatic detection (SIEFED) respectively. Additional experiments were performed to assess the effect of sevoflurane on the peroxidase and chlorination cycles of purified equine MPO using Amplex Red and 3’-(p-aminophenyl) fluorescein as fluorogenic substrates respectively.

Results  As compared with air alone, 1 hour exposure of whole blood to 4.6% sevoflurane in air significantly inhibited the release of total and active MPO by unstimulated and both fMLP- and CB + fMLP-stimulated PMNs but not by PMA-stimulated PMNs. Although 2.3% sevoflurane had no effect on total MPO release by unstimulated and stimulated PMNs, it significantly reduced the release of active MPO by unstimulated and fMLP-stimulated PMNs. Additionally, sevoflurane reversibly inhibited the activity of MPO, especially the peroxidase cycle of the enzyme.

Conclusions and clinical relevance  Although our experimental study was not designed to assess the effects of sevoflurane in vivo, this inhibition of MPO release and activity may have relevance for anaesthetized horses and deserves further studies to examine the clinical importance of these findings.

Ancillary